We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Ingevity
NGVT
$2.68B
| $7.72M | 0.01% |
108,113
-1,535
| -1% | -$121K |
|
1102
Avista
AVA
$3.24B
| $7.71M | 0.01% |
196,978
-27,343
| -12% | -$1.15M |
|
1103
Steven Madden
SHOO
$3.55B
| $7.71M | 0.01% |
191,873
-31,506
| -14% | -$1.3M |
|
|
NVTA
1104
DELISTED
Invitae Corporation
NVTA
| $7.7M | 0.01% |
270,899
-2,631
| -1% | -$77.1K |
|
|
TPH
1105
DELISTED
Tri Pointe Homes
TPH
| $7.68M | 0.01% |
365,540
-9,232
| -2% | -$208K |
|
1106
AGNC Investment
AGNC
$12.9B
| $7.67M | 0.01% |
486,715
-41,113
| -8% | -$666K |
|
|
RCM
1107
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.67M | 0.01% |
348,636
-7,065
| -2% | -$146K |
|
1108
United Natural Foods
UNFI
$2.85B
| $7.67M | 0.01% |
158,386
-22,875
| -13% | -$810K |
|
|
JWN
1109
DELISTED
Nordstrom
JWN
| $7.66M | 0.01% |
289,597
-23
| -0% | -$734 |
|
1110
Aaon
AAON
$7.77B
| $7.63M | 0.01% |
175,220
-26,713
| -13% | -$1.16M |
|
1111
Antero Resources
AR
$10.7B
| $7.61M | 0.01% |
404,641
+3,243
| +0.8% | +$47.3K |
|
|
IBTX
1112
DELISTED
Independent Bank Group, Inc.
IBTX
| $7.6M | 0.01% |
107,007
-13,157
| -11% | -$916K |
|
1113
Trinity Industries
TRN
$2.38B
| $7.52M | 0.01% |
276,694
-3,657
| -1% | -$101K |
|
|
GAP
1114
The Gap Inc
GAP
$7.37B
| $7.51M | 0.01% |
330,925
-9,143
| -3% | -$253K |
|
1115
Kirby Corp
KEX
$6.93B
| $7.5M | 0.01% |
156,334
-4,186
| -3% | -$232K |
|
1116
SouthState Bank Corp
SSB
$10.5B
| $7.49M | 0.01% |
100,283
-1,025
| -1% | -$73K |
|
1117
Emergent Biosolutions
EBS
$248M
| $7.46M | 0.01% |
149,003
+4,333
| +3% | +$262K |
|
1118
Vistra
VST
$47.4B
| $7.45M | 0.01% |
435,565
-96,325
| -18% | -$1.78M |
|
1119
Myriad Genetics
MYGN
$312M
| $7.43M | 0.01% |
230,270
-26,332
| -10% | -$874K |
|
1120
Sanmina
SANM
$10.9B
| $7.42M | 0.01% |
192,656
-25,196
| -12% | -$967K |
|
1121
WaFd
WAFD
$2.75B
| $7.4M | 0.01% |
215,629
-26,286
| -11% | -$855K |
|
1122
Allegiant Air
ALGT
$2.57B
| $7.38M | 0.01% |
37,730
-4,852
| -11% | -$931K |
|
|
AEL
1123
DELISTED
American Equity Investment Life Holding Company
AEL
| $7.36M | 0.01% |
248,927
-41,415
| -14% | -$1.29M |
|
|
SWAV
1124
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $7.35M | 0.01% |
35,694
+1,219
| +4% | +$239K |
|
1125
Yelp
YELP
$1.41B
| $7.34M | 0.01% |
197,244
-2,735
| -1% | -$104K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.